179 related articles for article (PubMed ID: 9619735)
1. A case of bone marrow mastocytosis associated with multiple myeloma.
Hagen W; Schwarzmeier J; Walchshofer S; Zojer N; Chott A; Sillaber C; Ackermann J; Simonitsch I; Bühring HJ; Drach J; Lechner K; Horny HP; Valent P
Ann Hematol; 1998; 76(3-4):167-74. PubMed ID: 9619735
[TBL] [Abstract][Full Text] [Related]
2. Systemic mastocytosis in association with chronic lymphocytic leukemia and plasma cell myeloma.
Du S; Rashidi HH; Le DT; Kipps TJ; Broome HE; Wang HY
Int J Clin Exp Pathol; 2010 Apr; 3(4):448-57. PubMed ID: 20490336
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow mastocytosis associated with IgM kappa plasma cell myeloma.
Stellmacher F; Sotlar K; Balleisen L; Valent P; Horny HP
Leuk Lymphoma; 2004 Apr; 45(4):801-5. PubMed ID: 15160959
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical properties of bone marrow mast cells in systemic mastocytosis: evidence for expression of CD2, CD117/Kit, and bcl-x(L).
Jordan JH; Walchshofer S; Jurecka W; Mosberger I; Sperr WR; Wolff K; Chott A; Bühring HJ; Lechner K; Horny HP; Valent P
Hum Pathol; 2001 May; 32(5):545-52. PubMed ID: 11381374
[TBL] [Abstract][Full Text] [Related]
5. Increased angiogenesis in the bone marrow of patients with systemic mastocytosis.
Wimazal F; Jordan JH; Sperr WR; Chott A; Dabbass S; Lechner K; Horny HP; Valent P
Am J Pathol; 2002 May; 160(5):1639-45. PubMed ID: 12000716
[TBL] [Abstract][Full Text] [Related]
6. Systemic mastocytosis with associated clonal haematological non-mast cell lineage diseases: a histopathological challenge.
Horny HP; Sotlar K; Sperr WR; Valent P
J Clin Pathol; 2004 Jun; 57(6):604-8. PubMed ID: 15166264
[TBL] [Abstract][Full Text] [Related]
7. Serum tryptase levels in patients with mastocytosis: correlation with mast cell burden and implication for defining the category of disease.
Sperr WR; Jordan JH; Fiegl M; Escribano L; Bellas C; Dirnhofer S; Semper H; Simonitsch-Klupp I; Horny HP; Valent P
Int Arch Allergy Immunol; 2002 Jun; 128(2):136-41. PubMed ID: 12065914
[TBL] [Abstract][Full Text] [Related]
8. Systemic mastocytosis with plasma cell dyscrasia: report of a case.
Pullarkat ST; Sedarat F; Paquette R; Said J
Leuk Res; 2008 Jul; 32(7):1160-3. PubMed ID: 18061667
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic criteria and classification of mastocytosis: a consensus proposal.
Valent P; Horny HP; Escribano L; Longley BJ; Li CY; Schwartz LB; Marone G; Nuñez R; Akin C; Sotlar K; Sperr WR; Wolff K; Brunning RD; Parwaresch RM; Austen KF; Lennert K; Metcalfe DD; Vardiman JW; Bennett JM
Leuk Res; 2001 Jul; 25(7):603-25. PubMed ID: 11377686
[TBL] [Abstract][Full Text] [Related]
10. Hodgkin's lymphoma is a rare form of clonal haematological non-mast cell disease in systemic mastocytosis.
Gasljevic G; Grcar-Kuzmanov B; Grosel A; Sever M; Gazic B; Kloboves-Prevodnik V
Diagn Pathol; 2015 Mar; 10():5. PubMed ID: 25881198
[TBL] [Abstract][Full Text] [Related]
11. Detection of c-kit mutation Asp 816 to Val in microdissected bone marrow infiltrates in a case of systemic mastocytosis associated with chronic myelomonocytic leukaemia.
Sotlar K; Marafioti T; Griesser H; Theil J; Aepinus C; Jaussi R; Stein H; Valent P; Horny HP
Mol Pathol; 2000 Aug; 53(4):188-93. PubMed ID: 11040941
[TBL] [Abstract][Full Text] [Related]
12. Telangiectasia macularis eruptiva perstans and multiple myeloma.
Bachmeyer C; Guillemette J; Blum L; Turc Y; Dhôte R; Fermand JP; Aractingi S
J Am Acad Dermatol; 2000 Nov; 43(5 Pt 2):972-4. PubMed ID: 11044837
[TBL] [Abstract][Full Text] [Related]
13. Venom immunotherapy in patients with mastocytosis and hymenoptera venom anaphylaxis.
González-de-Olano D; Alvarez-Twose I; Vega A; Orfao A; Escribano L
Immunotherapy; 2011 May; 3(5):637-51. PubMed ID: 21554093
[TBL] [Abstract][Full Text] [Related]
14. Acute myeloid leukaemia with t(8;21) associated with "occult" mastocytosis. Report of an unusual case and review of the literature.
Bernd HW; Sotlar K; Lorenzen J; Osieka R; Fabry U; Valent P; Horny HP
J Clin Pathol; 2004 Mar; 57(3):324-8. PubMed ID: 14990611
[TBL] [Abstract][Full Text] [Related]
15. A case of 'smouldering' mastocytosis with high mast cell burden, monoclonal myeloid cells, and C-KIT mutation Asp-816-Val.
Jordan JH; Fritsche-Polanz R; Sperr WR; Mitterbauer G; Födinger M; Schernthaner GH; Christian Bankl H; Gebhart W; Chott A; Lechner K; Valent P
Leuk Res; 2001 Jul; 25(7):627-34. PubMed ID: 11377687
[TBL] [Abstract][Full Text] [Related]
16. Osteoporosis as the sole presentation of bone marrow mastocytosis.
Lidor C; Frisch B; Gazit D; Gepstein R; Hallel T; Mekori YA
J Bone Miner Res; 1990 Aug; 5(8):871-6. PubMed ID: 2239371
[TBL] [Abstract][Full Text] [Related]
17. Hematologic manifestations of systemic mast cell disease: a prospective study of laboratory and morphologic features and their relation to prognosis.
Lawrence JB; Friedman BS; Travis WD; Chinchilli VM; Metcalfe DD; Gralnick HR
Am J Med; 1991 Dec; 91(6):612-24. PubMed ID: 1750431
[TBL] [Abstract][Full Text] [Related]
18. Impact of centralized evaluation of bone marrow histology in systemic mastocytosis.
Jawhar M; Schwaab J; Horny HP; Sotlar K; Naumann N; Fabarius A; Valent P; Cross NC; Hofmann WK; Metzgeroth G; Reiter A
Eur J Clin Invest; 2016 May; 46(5):392-7. PubMed ID: 26914980
[TBL] [Abstract][Full Text] [Related]
19. The Spectrum of Aggressive Mastocytosis: A Workshop Report and Literature Review.
Leguit R; Hebeda K; Kremer M; van der Walt J; Gianelli U; Tzankov A; Orazi A
Pathobiology; 2020; 87(1):2-19. PubMed ID: 31802761
[TBL] [Abstract][Full Text] [Related]
20. Myelomastocytic overlap syndromes: biology, criteria, and relationship to mastocytosis.
Valent P; Sperr WR; Samorapoompichit P; Geissler K; Lechner K; Horny HP; Bennett JM
Leuk Res; 2001 Jul; 25(7):595-602. PubMed ID: 11377685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
